- D-Dimer Testing
- Prothrombin Time Testing
- Platelet Function Tests
- Activated Clotting Time Testing
- Anti-Factor Xa Tests
- Others
Coagulation Testing Market size was valued at USD 1.6 billion in 2022 and is poised to grow at a CAGR of 6.8% from 2023 to 2029. Coagulation is the complex process in which the blood clots are formed and helps to control the bleeding. The coagulation involves a platelet (cellular) and coagulation (protein) factor. When the endothelium (lining of a blood vessel) is damaged, the platelets form a plug at the site of injury, where the proteins in the bloodsream plasma respond in a chemical reaction which results in the formation of fibrin strands that reinforces the platelet plug. There are various bleeding disorders that causes abnormal bleeding, which are either acquired or inherited. By coagulation testing, the time taken for the blood to clot and its ability to clot can be measured.
Coagulation Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.8%
Largest Market
North-America
Fastest Growing Market
Asia-Pacific
Coagulation Testing Market Dynamics
Increase in the prevalence of hemostatic diseases and various chronic diseases such as liver diseases and thrombophilia is majorly driving the growth of the coagulation testing market. The technological advancements and developing healthcare infrastructure is attributed for the growth of the coagulation testing market. Life-style related conditions such as obesity, diabetes are expected to drive the growth of the coagulation testing market. However, the high cost involved in the treatment is likely to hinder the growth of the market. The poor reimbursement policies is another factor that is hindering the growth of the market.
North-America Got Significant Share
Coagulation Testing Market Regional Analysis
Geographically, global coagulation testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America coagulation testing market is growing owing to increase in the blood related diseases. According to the Centers for Disease Control and Prevention, hemophilia A affects 1 in 5,000 males. Almost 400 babies are born with hemophilia A every year. With the studies conducted in 1994, about 17,000 people were suffering from hemophilia at that time and currently it’s estimated that there are 20,000 people who would suffer from hemophilia basing on the birth and death rate since 1994. Following the North America are the regions of Europe and Asia Pacific. The Asia Pacific region is expected show the growth in the forecasted period owing to its higher awareness among the patient pool and developing healthcare infrastructure.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Coagulation Testing Market Segmentation
By Test Type
By Application
- Hemophilia
- Liver Disorders
- Diabetes
- Others
By Technology
- Optical Technology
- Electrochemical Technology
- Mechanical Technology
- Others
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
Frequently Asked Questions
The coagulation testing market size was valued at USD 1.6 billion in 2022
Increasing Prevalence of Chronic Blood Disorders
Asia Pacific is the fastest-growing for coagulation testing market
| 1. Executive Summary |
| 2. Global Coagulation Testing Market Introduction |
| 2.1.Global Coagulation Testing Market - Taxonomy |
| 2.2.Global Coagulation Testing Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.Application |
| 2.2.3.Technology |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Coagulation Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Coagulation Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Coagulation Testing Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. D-Dimer Testing |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Prothrombin Time Testing |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Platelet Function Tests |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Activated Clotting Time Testing |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Anti-Factor Xa Tests |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Coagulation Testing Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hemophilia |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liver Disorders |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diabetes |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Coagulation Testing Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Optical Technology |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Electrochemical Technology |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Mechanical Technology |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Coagulation Testing Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals and Clinics |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Laboratories |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Home Care Settings |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Coagulation Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Coagulation Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.D-Dimer Testing |
| 10.1.2.Prothrombin Time Testing |
| 10.1.3.Platelet Function Tests |
| 10.1.4.Activated Clotting Time Testing |
| 10.1.5.Anti-Factor Xa Tests |
| 10.1.6.Others |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hemophilia |
| 10.2.2.Liver Disorders |
| 10.2.3.Diabetes |
| 10.2.4.Others |
| 10.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical Technology |
| 10.3.2.Electrochemical Technology |
| 10.3.3.Mechanical Technology |
| 10.3.4.Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals and Clinics |
| 10.4.2.Diagnostic Laboratories |
| 10.4.3.Home Care Settings |
| 10.4.4.Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Coagulation Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.D-Dimer Testing |
| 11.1.2.Prothrombin Time Testing |
| 11.1.3.Platelet Function Tests |
| 11.1.4.Activated Clotting Time Testing |
| 11.1.5.Anti-Factor Xa Tests |
| 11.1.6.Others |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hemophilia |
| 11.2.2.Liver Disorders |
| 11.2.3.Diabetes |
| 11.2.4.Others |
| 11.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical Technology |
| 11.3.2.Electrochemical Technology |
| 11.3.3.Mechanical Technology |
| 11.3.4.Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals and Clinics |
| 11.4.2.Diagnostic Laboratories |
| 11.4.3.Home Care Settings |
| 11.4.4.Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Coagulation Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.D-Dimer Testing |
| 12.1.2.Prothrombin Time Testing |
| 12.1.3.Platelet Function Tests |
| 12.1.4.Activated Clotting Time Testing |
| 12.1.5.Anti-Factor Xa Tests |
| 12.1.6.Others |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hemophilia |
| 12.2.2.Liver Disorders |
| 12.2.3.Diabetes |
| 12.2.4.Others |
| 12.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Optical Technology |
| 12.3.2.Electrochemical Technology |
| 12.3.3.Mechanical Technology |
| 12.3.4.Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals and Clinics |
| 12.4.2.Diagnostic Laboratories |
| 12.4.3.Home Care Settings |
| 12.4.4.Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Coagulation Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.D-Dimer Testing |
| 13.1.2.Prothrombin Time Testing |
| 13.1.3.Platelet Function Tests |
| 13.1.4.Activated Clotting Time Testing |
| 13.1.5.Anti-Factor Xa Tests |
| 13.1.6.Others |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Hemophilia |
| 13.2.2.Liver Disorders |
| 13.2.3.Diabetes |
| 13.2.4.Others |
| 13.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Optical Technology |
| 13.3.2.Electrochemical Technology |
| 13.3.3.Mechanical Technology |
| 13.3.4.Others |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals and Clinics |
| 13.4.2.Diagnostic Laboratories |
| 13.4.3.Home Care Settings |
| 13.4.4.Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Coagulation Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.D-Dimer Testing |
| 14.1.2.Prothrombin Time Testing |
| 14.1.3.Platelet Function Tests |
| 14.1.4.Activated Clotting Time Testing |
| 14.1.5.Anti-Factor Xa Tests |
| 14.1.6.Others |
| 14.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Hemophilia |
| 14.2.2.Liver Disorders |
| 14.2.3.Diabetes |
| 14.2.4.Others |
| 14.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Optical Technology |
| 14.3.2.Electrochemical Technology |
| 14.3.3.Mechanical Technology |
| 14.3.4.Others |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals and Clinics |
| 14.4.2.Diagnostic Laboratories |
| 14.4.3.Home Care Settings |
| 14.4.4.Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Alere Inc. (U.S) |
| 15.2.2.Hoffmann-La Roche Ltd. (Europe) |
| 15.2.3.Accriva Diagnostics (U.S) |
| 15.2.4.CoaguSense, Inc. (U.S) |
| 15.2.5.Siemens Healthcare Private Limited (Europe) |
| 15.2.6.Bio/Data Corporation (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Alere Inc. (U.S)
- Hoffmann-La Roche Ltd. (Europe)
- Accriva Diagnostics (U.S)
- CoaguSense, Inc. (U.S)
- Siemens Healthcare Private Limited (Europe)
- Bio/Data Corporation (U.S)
- SenGenix Inc. (U.S)
- Instrumentation Laboratory (U.S)